Profiel
Jeffrey R.
Latts is an Independent Director at Allos Therapeutics, Inc. since 2007.
Previously, he served as the Chief Medical Officer at Berlex, Inc. from 1990 to 2001.
He then worked as the Executive Vice President at Exelixis, Inc. from 2001 to 2007.
Additionally, he has held positions as the Chief Medical Advisor at Virobay, Inc. and as the Vice President-Clinical Research at Wyeth-Ayerst Research.
Dr. Latts completed his undergraduate and doctorate degrees at the University of Minnesota.
Actieve functies van Jeffrey R. Latts
| Bedrijven | Functie | Begin |
|---|---|---|
Allos Therapeutics, Inc.
Allos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets anti-cancer therapeutics | Directeur/Bestuurslid | 25-04-2007 |
Eerdere bekende functies van Jeffrey R. Latts
| Bedrijven | Functie | Einde |
|---|---|---|
| EXELIXIS, INC. | Corporate Officer/Principal | 12-01-2007 |
Berlex, Inc.
Berlex, Inc. Pharmaceuticals: MajorHealth Technology Manufactured pharmaceutical products | Hoofd Techniek/Wetenschap/O&O | 01-01-2001 |
Virobay, Inc.
Virobay, Inc. Pharmaceuticals: MajorHealth Technology Develops protease inhibitors for the treatment of neuropathic pain, cancer, autoimmune and liver diseases | Corporate Officer/Principal | - |
Wyeth-Ayerst Research | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Jeffrey R. Latts
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 6 |
|---|---|
Berlex, Inc.
Berlex, Inc. Pharmaceuticals: MajorHealth Technology Manufactured pharmaceutical products | Health Technology |
Allos Therapeutics, Inc.
Allos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets anti-cancer therapeutics | Health Technology |
Exelixis, Inc.
Exelixis, Inc. Pharmaceuticals: MajorHealth Technology Operates as a cancer drug discovery company | Health Technology |
Virobay, Inc.
Virobay, Inc. Pharmaceuticals: MajorHealth Technology Develops protease inhibitors for the treatment of neuropathic pain, cancer, autoimmune and liver diseases | Health Technology |
University of Minnesota
University of Minnesota Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Wyeth-Ayerst Research |
















